万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>牙科与口腔外科

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology《口腔外科学、口腔医学、口腔病理学与口腔放射学》 (官网投稿)

简介
  • 期刊简称OR SURG OR MED OR PA
  • 参考译名《口腔外科学、口腔医学、口腔病理学与口腔放射学》
  • 核心类别 SCI期刊(2019), SCIE期刊(2019), 外文期刊,
  • IF影响因子1.601
  • 自引率8.40%
  • 主要研究方向医学-DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科

主要研究方向:

等待设置主要研究方向
医学-DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology《口腔外科学、口腔医学、口腔病理学与口腔放射学》(月刊). Oral Surgery, Oral Medicine, Oral Pathology and ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://www.oooojournal.net/

https://www.journals.elsevier.com/oral-surgery-oral-medicine-oral-pathology-and-oral-radiology

3、投稿网址:

https://www.editorialmanager.com/TRIPLEO

4、官网邮箱:如下。

5、期刊刊期:月刊,一年出版12期。

202161日星期二

                             

 

期刊邮箱【官网信息】

 

General inquiries and communications regarding editorial management should be addressed to Alice M. Landwehr, Managing Editor: tripleOjournal@gmail.com.

General correspondence to the Editor-in-Chief, Mark W. Lingen, DDS, PhD: Mark.Lingen@uchospitals.edu

Publisher-specific inquiries should be addressed to: Jane Ryley, Elsevier Inc., 3251 Riverport Lane, Maryland Heights, MO 63043; e-mail: J.Ryley@Elsevier.com.

Issue Manager, Elizabeth Rajesh; e-mail: e.rajesh@Elsevier.com.

 

投稿须知【官网信息】

 

Author Information

Section Scope Statements

The Oral and Maxillofacial Surgery Section aims to publish an extensive range of original articles that advances patient care through enhanced understanding of diagnosis, surgical and adjunctive treatment of diseases, and injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial regions. The section also seeks research regarding both the basic science of and management of persons with oral and maxillofacial conditions. Articles presenting ethical, original, well-documented, and reproducible research are given preference.

The Oral Medicine Section aims to publish a broad range of original articles that help clinicians understand more thoroughly the pathobiology, etiology, diagnosis, prevention, and management of oral conditions related to underlying medical conditions, including diseases of the head, neck, and oral mucosal structures, orofacial pain conditions, salivary gland disorders, and taste disorders. The section also seeks research regarding the dental management of persons with medical problems and/or complicated medical conditions. The published findings must contribute substantively to the body of oral medicine literature and should lead to improved clinical decision-making and enhanced care of medically-related disorders or conditions affecting the oral and maxillofacial region. Articles presenting original, well-documented, and reproducible research are preferred.

The Oral and Maxillofacial Pathology Section encourages the submission of original articles of high scientific quality that investigate the pathogenesis, diagnosis, and management of diseases affecting the oral and maxillofacial region. Submitted manuscripts may summarize findings from clinical, translational, or basic research in the broad field of oral and maxillofacial pathology but must contribute substantively to the body of knowledge in this field and should be of obvious clinical and/or diagnostic significance to the practicing oral and maxillofacial pathologist. Areas of focus may include the investigation of disease pathogenesis, the diagnosis of disease using microscopic, clinical, radiographic, biochemical, molecular, or other methods as well as the natural history and management of patients with various conditions of the head, neck, and oral mucosal structures. Diagnostic accuracy studies should conform to the principles of the STARD document http://www.stard-statement.org. Articles presenting novel and reproducible research that introduce new knowledge and observations are especially encouraged. This section also welcomes the submission of topical review papers on relevant subjects.

The Oral and Maxillofacial Radiology Section publishes original contributions to the advancement of oral and maxillofacial radiology and related imaging sciences. The section considers original clinical and experimental research papers, reports of technological developments, extensive systematic reviews of the literature, and invited papers on subjects that will appeal to researchers and clinicians involved in diagnostic imaging of hard and soft tissues of the head and neck. Topics of interest include the efficacy of imaging systems using ionizing and non-ionizing radiation in the diagnosis of head and neck disease; molecular imaging; artificial intelligence and computer-assisted diagnosis; craniofacial analysis; image-guided surgical navigation; image processing; radiation physics and dosimetry; and radiation biology, safety, and protection. The section also seeks extensive case series representing various expressions of particular conditions, descriptions of innovative imaging technique applications to these series, and description of novel imaging features. Published manuscripts should assist clinicians in developing evidence-based practice and provide improved clinical decision-making regarding the performance of specific techniques and interpretation of resulting images. Diagnostic accuracy studies should conform to the principles of the STARD document http://www.stard-statement.org).

Types of Papers

1. Original Research Article. Reports of original research (preclinical, clinical, or translational) that are well-documented, novel, and significant. Original research manuscripts will be organized into six parts: (1) Abstract; (2) Introduction; (3) Materials and Methods; (4) Results; (5) Discussion; (6) References.

2. Review article. Manuscripts that review the current status of a given topic, diagnosis, or treatment. These manuscripts should not be an exhaustive review of the literature but rather should be a review of contemporary thought with respect to the topic. Systematic reviews and meta-analyses manuscripts should follow PRISMA (http://www.prisma-statement.org) and the Institute of Medicines' guidelines (http://www.iom.edu/Reports/2011/Finding-What-Works-in-Health-Care-Standards-for-Systematic-Reviews/Standards.aspx).

3. Clinicopathologic Conference (CPC). Manuscripts that document interesting, challenging, or unusual cases that present unexpected or interesting diagnostic challenges. The presentation should simulate clinical work-up, including the formulation of a detailed and well thought out differential diagnosis. The complete diagnostic evaluation, management, and follow-up must be included. CPC articles must be organized into six parts: (1) Title: Provide a descriptive clinical title that does not reveal the final diagnosis. (2) Clinical presentation: Describe the clinical and imaging characteristics of the lesion. Use clinical photographs and radiographs as appropriate. (3) Differential diagnosis: List and discuss lesions to be considered as reasonable diagnostic possibilities. The authors are reminded that the most important part of the CPC manuscript is the clinical differential diagnosis, where the authors guide the readership through their own diagnostic thought process. This will require the formulation of a list of the most probable diagnostic possibilities (ideally at least 5-6 entities) based on the clinical presentation, medical history, and/or radiographic studies. (4) Diagnosis: Histopathologic findings illustrated with appropriate photomicrographs. (5) Management: Describe the treatment of the patient and response to treatment. (6) Discussion: Concentrate on the most interesting aspect(s) of the case. No abstract is needed for CPC manuscripts. Limit the number of references to no more than 25.

4. Case Reports. These types of publications often add little to the scientific knowledge base. However, excellent case reports may be published as online only papers if they meet certain criteria, such as: (1) rare or unusual lesions/conditions that need documentation, (2) well-documented cases showing unusual or "atypical" clinical or microscopic features or behavior, or (3) cases showing good long-term follow-up information, particularly in areas in which good statistics on results of treatment are needed. A case report should either present unique features of the condition or lesion, novel treatment regimens, or provide the basis for a new plausible medical theory about the pathogenesis of a particular disease or condition so clinicians can provide better care regarding patients with chronic and painful conditions relevant to medical disorders and/or medical therapy. Providing Virtual Microscope image/s is highly encouraged for Case Reports (see also below).

Enhancements such as Virtual Microscope images, DICOM files, and video clips are not mandatory for initial submission but are encouraged for all article types; if editors request a revision, they may specifically request submission of these types of files with the revised manuscript.

General inquiries and communications regarding editorial management should be addressed to Alice M. Landwehr, Managing Editor: tripleOjournal@gmail.com.

General correspondence to the Editor-in-Chief, Mark W. Lingen, DDS, PhD: Mark.Lingen@uchospitals.edu

Publisher-specific inquiries should be addressed to: Jane Ryley, Elsevier Inc., 3251 Riverport Lane, Maryland Heights, MO 63043; e-mail: J.Ryley@Elsevier.com.

Issue Manager, Elizabeth Rajesh; e-mail: e.rajesh@Elsevier.com.

Ethics in publishing

Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.

Informed consent and patient details

Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

If there is any overlap between the submission and any other material, published or submitted, detail the nature of and reason for the overlap for the editors' assessment. Although poster presentations and abstracts are not considered duplicate publication, they should be stated on the title page. Further information about Elsevier's standards for publication ethics is available at https://www.elsevier.com/publishingethics.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Preprints

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Author contributions

For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example

Authorship

All authors should have made substantial contributions to all of the following:

Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND

Drafting the work or revising it critically for important intellectual content; AND

Final approval of the version to be published; AND

Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All authors must have seen and approved the submission of the manuscript and be willing to take responsibility for the entire manuscript. All persons listed as authors must meet the criteria for authorship according to the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication" available at http://www.icmje.org. All four of these conditions must be met by each author. No additional authors can be added after submission unless editors receive agreement from all authors and detailed information is supplied as to why the author list should be amended. Persons who contribute to the effort in supporting roles should not be included as authors; they should be acknowledged at the end of the paper (see Acknowledgments below).

Changes to authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.

Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

Registration of clinical trials

Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.

Clinical trial results

In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.

Article transfer service

This journal is part of our Article Transfer Service. This means that if the Editor feels your article is more suitable in one of our other participating journals, then you may be asked to consider transferring the article to one of those. If you agree, your article will be transferred automatically on your behalf with no need to reformat. Please note that your article will be reviewed again by the new journal. More information.

Copyright

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.

For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.

Author rights

As an author you (or your employer or institution) have certain rights to reuse your work. More information.

Elsevier supports responsible sharing

Find out how you can share your research published in Elsevier journals.

Role of the funding source

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

Open access

Please visit our Open Access page for more information.

Language (usage and editing services)

Please write your text in standard, grammatical English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop ( https://webshop.elsevier.com/language-editing-services/language-editing/) or visit our customer support site ( https://service.elsevier.com) for more information. Such assistance does not guarantee acceptance but may enhance the review, improve the chance of acceptance, and reduce the time until publication if the article is accepted.

Submission

Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.If the manuscript is accepted, the Editors reserve the right to determine whether it will be published in the print edition or solely in the Internet edition of the Journal.

Submit your article

Please submit your article via https://www.editorialmanager.com/tripleO/default.aspx.

……

更多详情:

https://www.oooojournal.net/content/authorinfo


投稿问答最小化  关闭